FNGAX
Price
$18.57
Change
+$0.08 (+0.43%)
Updated
Jul 3 closing price
Net Assets
894.31M
RERHX
Price
$60.25
Change
+$0.12 (+0.20%)
Updated
Jul 3 closing price
Net Assets
134.48B
Interact to see
Advertisement

FNGAX vs RERHX

Header iconFNGAX vs RERHX Comparison
Open Charts FNGAX vs RERHXBanner chart's image
Franklin Intl Growth A
Price$18.57
Change+$0.08 (+0.43%)
VolumeN/A
Net Assets894.31M
American Funds EUPAC R5E
Price$60.25
Change+$0.12 (+0.20%)
VolumeN/A
Net Assets134.48B
FNGAX vs RERHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FNGAX vs. RERHX commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNGAX is a StrongBuy and RERHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERHX has more cash in the bank: 134B vs. FNGAX (894M). FNGAX pays higher dividends than RERHX: FNGAX (1.70) vs RERHX (0.85). FNGAX was incepted earlier than RERHX: FNGAX (17 years) vs RERHX (10 years). FNGAX (1.20) is less costly to investors than RERHX (0.62). RERHX is a more actively managed with annual turnover of: 30.00 vs. FNGAX (17.56). RERHX has a lower initial minimum investment than FNGAX: RERHX (250) vs FNGAX (1000). FNGAX annual gain was more profitable for investors over the last year : 10.35 vs. RERHX (5.43). RERHX return over 5 years is better than : 17.72 vs. FNGAX (6.62).
FNGAXRERHXFNGAX / RERHX
Total Expense Ratio1.120.62181%
Annual Report Gross Expense Ratio1.200.62194%
Fund Existence17 years10 years-
Gain YTD14.96613.146114%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets894M134B1%
Annual Yield % from dividends1.700.85201%
Returns for 1 year10.355.43191%
Returns for 3 years32.8930.27109%
Returns for 5 years6.6217.7237%
Returns for 10 years73.04N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRDF3.660.07
+1.95%
Cardiff Oncology
HOMB29.810.29
+0.98%
Home BancShares
HY42.540.27
+0.64%
Hyster-Yale Inc.
LICN4.18N/A
N/A
Lichen International Limited
NTES132.85-0.15
-0.11%
NetEase